Virginia Retirement Systems’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
358,500
+253,000
| +240% | +$13.9M | 0.14% | 178 |
|
|
2025
Q1 | $7.46M | Buy |
+105,500
| New | +$7.46M | 0.06% | 252 |
|
|
2022
Q1 | $910K | Buy |
+11,800
| New | +$910K | 0.01% | 670 |
|
|
2015
Q4 | $359K | Buy |
3,425
+48
| +1% | +$5.03K | 0.01% | 799 |
|
|
2015
Q3 | $356K | Buy |
3,377
+59
| +2% | +$6.22K | 0.01% | 782 |
|
|
2015
Q2 | $454K | Buy |
3,318
+69
| +2% | +$9.44K | 0.01% | 740 |
|
|
2015
Q1 | $405K | Buy |
3,249
+221
| +7% | +$27.5K | 0.01% | 757 |
|
|
2014
Q4 | $274K | Buy |
3,028
+26
| +0.9% | +$2.35K | ﹤0.01% | 840 |
|
|
2014
Q3 | $217K | Buy |
+3,002
| New | +$217K | ﹤0.01% | 899 |
|
|
2013
Q3 | – | Sell |
-3,964
| Closed | -$221K | – | 831 |
|
|
2013
Q2 | $221K | Buy |
+3,964
| New | +$221K | ﹤0.01% | 900 |
|